Cdk1 and BRCA1 target γ-tubulin to microtubule domains

被引:11
|
作者
Hubert, Thomas [2 ]
Vandekerckhove, Joel [2 ]
Gettemans, Jan [1 ,2 ]
机构
[1] Univ Ghent, VIB, Dept Med Prot Res, Fac Med & Hlth Sci, B-9000 Ghent, Belgium
[2] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium
关键词
Cdk1; BRCA1; gamma-Tubulin; Microtubule; DNA damage response; RNA-POLYMERASE-II; DNA-DAMAGE; BRCA1-DEPENDENT UBIQUITINATION; MAMMALIAN-CELLS; RING COMPLEX; C-MYC; NUCLEATION; LOCALIZATION; CHECKPOINT; BINDING;
D O I
10.1016/j.bbrc.2011.09.064
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DNA damage is a critical event that requires an appropriate cellular response. This is mediated by checkpoint proteins such as Cdk1 that controls S/G2 and G2/M transition. Cdk1 is required for BRCA1 transport to DNA damage sites inside the nucleus where BRCA1 functions as a scaffold to initiate a signaling cascade. BRCA1 is a multifunctional protein that also ubiquitinates gamma-tubulin and, consequently, inhibits microtubule nucleation at the centrosome. Here, we report that gamma-tubulin also localizes at confined areas in the microtubule network. Nocodazole-mediated microtubule depolymeration results in disappearance of this gamma-tubulin fraction, while microtubule stabilization by taxol preserves this structure. Surprisingly, overexpression of Cdk1 or BRCA1 greatly expands the gamma-tubulin coating of microtubules, suggesting that the microtubule-bound gamma-tubulin is involved in DNA damage response. This is in accordance with numerous reports of microtubule-associated DNA damage proteins, such as p53, that are transported to the nucleus when DNA damage occurs. gamma-Tubulin itself has been reported to form complexes with DNA repair proteins in the nucleus. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:240 / 245
页数:6
相关论文
共 50 条
  • [21] CDK1 in the driving seat
    Anne Blewett
    Nature Reviews Molecular Cell Biology, 2007, 8 : 755 - 755
  • [22] BRCA1 as Target for Breast Cancer Prevention and Therapy
    Romagnolo, Alberto P. G.
    Romagnolo, Donato F.
    Selmin, Ornella I.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (01) : 4 - 14
  • [23] BRCA1 methylation and BRCA1 mutations in ovarian cancer
    Bol, Guus Martinus
    van Diest, Paul Joannes
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 459 - 459
  • [24] CDK1 serves as a potential prognostic biomarker and target for lung cancer
    Li, Mingyao
    He, Fenyi
    Zhang, Zhanchun
    Xiang, Zhenfei
    Hu, Danfei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (02)
  • [25] BRCA1 and BRCA1 in cell response to genotoxic lesions
    Feunteun, J
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S302 - S302
  • [26] CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
    Ying, Xue
    Che, Xuan
    Wang, Jianzhang
    Zou, Gen
    Yu, Qin
    Zhang, Xinmei
    JOURNAL OF CANCER, 2021, 12 (08): : 2206 - 2215
  • [27] BRCA1 regulates centrosome function by inhibiting microtubule nucleation activity
    Sankaran, S
    Starita, LM
    Parvin, JD
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 408A - 409A
  • [28] Functional assessment of intrinsic disorder central domains of BRCA1
    Yadav, Lumbini R.
    Rai, Sharad
    Hosur, M. V.
    Varma, Ashok K.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (11): : 2469 - 2478
  • [29] Cdk1 regulates centrosome separation by restraining proteolysis of microtubule-associated proteins
    Crasta, Karen
    Huang, Phillips
    Morgan, Garry
    Winey, Mark
    Surana, Uttam
    EMBO JOURNAL, 2006, 25 (11): : 2551 - 2563
  • [30] Cyclin A/Cdk1 Targets for Mitotic Regulation of Kinetochore-Microtubule Attachment Stability
    Dumitru, A.
    Rusin, S.
    Kettenbach, A.
    Compton, D.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26